RB
CNTB

Richmond Brothers’s Connect Biopharma Holdings CNTB Stock Holding History

Richmond Brothers’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
535,612
+59,028
+12% +$143K 0.66% 47
2026
Q1 		$1.25M Buy
476,584
+303,099
+175% +$790K 0.83% 22
2025
Q4 		$489K Buy
+173,485
New +$370K 0.31% 27

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Richmond Brothers's CNTB Position: Q2 2026 in Review

Richmond Brothers increased its Connect Biopharma Holdings (CNTB) stake by 12% in Q2 2026, buying an estimated $143K and bringing the position to 535,612 shares worth $1.27M. The position accounts for 0.66% of the portfolio, ranked #47.

Richmond Brothers first reported a position in CNTB in Q4 2025 and has held it in 3 quarters since. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Richmond Brothers held 535,612 shares of Connect Biopharma Holdings worth $1.27M as of Q2 2026.
  • Richmond Brothers bought 59,028 Connect Biopharma Holdings shares in Q2 2026, an estimated $143K.
  • Connect Biopharma Holdings made up 0.66% of Richmond Brothers's portfolio in Q2 2026, its #47 holding.
  • Richmond Brothers first reported a position in Connect Biopharma Holdings in Q4 2025 and has held it in 3 quarters since.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Richmond Brothers's 13F filing for Q2 2026, filed 11 Aug 2026.